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In the course of recent studies aimed at elucidating the biochemical mechanism 
of cachexia in  rabbits  infected with  Trypanosoma  brucei,  it  was  noted (1)  that 
animals  with  a  minimal  parasite  burden  became  moribund  and  exhibited  an 
extreme  hypertriglyceridemia,  with  a  marked  elevation  of  plasma  very  low 
density lipoprotein (VLDL).I The hypertriglyceridemic state was remarkable in 
view of the severe wasting diathesis that accompanied this experimental infection. 
The  elevation  of plasma  VLDL  was  shown  to  result  from  a  clearing  defect, 
caused by a loss of peripheral tissue lipoprotein lipase (LPL) activity. 
A  similar  deficiency of LPL activity was  noted (2)  in  C3H/HeN  mice after 
administration  of Escherichia  coli iipopolysaccharide (LPS). In contrast, the loss 
of LPL activity was not demonstrable in C3H/HeJ  mice, which are genetically 
resistant to LPS. This resistance to endotoxin-induced LPL deficiency could be 
circumvented by the administration of serum obtained from endotoxin-sensitive 
animals that had been injected with LPS 2 h previously. Similarly (2, 3), resistance 
could be overcome by injecting conditioned medium from endotoxin-stimulated 
thioglycollate-elicited peritoneal macrophages, obtained from sensitive mice. 
Macrophages and macrophage cell lines (i.e., RAW 264.7) were subsequently 
shown to elaborate, in response to endotoxin (4) or other bacterial and protozoal 
products (5), a monokine that could suppress the activity of LPL in the adipocyte 
cell  line  3T3-L1.  The  mechanism  of LPL suppression  appears  to  involve the 
selective inhibition of LPL biosynthesis. 
In  the  present paper,  we  report the  isolation  of cachectin,  the  macrophage 
factor that suppresses LPL activity in 3T3-L1 cells. The purified monokine is a 
This work was supported in part by grant 1 K  11 AM01314 01 from the National Institutes of Health 
and grant 84077 from the Rockefeller Foundation. Address correspondence to B. Beutler. Present 
address of J. Mahoney is: Department  of Surgery, University of Minnesota Medical School, 516 
Delaware Street S.E., Minneapolis, MN 55455. 
l Abbreviations used in this paper:  Con A, concanavalin A; DME, Dulbecco's modified Eagle's 
medium; FBS, fetal bovine serum; IL-1, -2, interleukin 1 and 2; LAF, leukocyte-activating factor; 
LPL, lipoprotein lipase; LPS, lipopolysaccharide;  PBS, phosphate-buffered saline; PTS, percent total 
suppression; RBC, erythrocytes; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electropho- 
resis; TNF, tumor necrosis factor; VLDL, very low density lipopolysaccharide. 
984  J. ExP. MED. © The Rockefeller University Press • 0022-1007185/05/0984112 $1.00 
Volume 161  May 1985  984-995 BEUTLER  ET  AL.  985 
17  kilodalton  protein  that  binds  to adipocytes and  several  other  cells  types,  by 
means of specific high affinity receptors. 
Materials  and  Methods 
3T3-LI  Cell Culture and Bioassay.  3T3-L1  cells (6-8) were plated  in 24-well  Linbro 
plates (Flow  Laboratories,  Inc., McLean,  VA) at a  density of 100,000  cells per well  in 
Dulbecco's modified  Eagle's  medium  (DME)  (Gibco  Laboratories,  Grand  Island,  NY) 
supplemented with  10% calf serum, and maintained at 37 °C in a  10% COs environment. 
Medium was changed every other day; after  1 wk, cells were differentiated by incubation 
for 48 h  in medium supplemented with  10% fetal bovine serum (FBS),  10 gg/ml bovine 
insulin, 0.5 mM methylisobutylxanthine, and 1.0 ~M dexamethasone. Differentiated cells 
were maintained in medium containing  10% FBS and 50 ng/ml bovine insulin (changed 
every other day) until their use for bioassay or cachectin-binding studies  1 wk later. 
Samples  to  be  assayed,  in  volumes  _<0.1 ml,  were  applied  to  individual  wells  of 
differentiated 3T3-L1 cells, each containing 1.0 ml of medium, and placed in a  10% CO~ 
incubator at 37°C for 12-18 h. At the end of this incubation, the medium was aspirated 
and replaced with 0.5 ml of DME containing 10%  FBS, 50 ng/ml insulin, and  10 U/ml 
heparin.  After 1 h at 37 °C, the heparin-releasable  LPL activity was measured according 
to the method of Nilsson-Ehle and Schotz (9). 
Percent of total LPL suppression (PTS) in a sample with LPL activity x was defined as 
follows: PTS =  (C -  x/C -  m) ×  100, where C is the LPL activity produced by wells of 
3T3-L1  cells  that  have  not  been  exposed  to  cachectin,  and  m  is  the  LPL activity of 
heparinized  medium  alone.  To avoid day-to-day assay variability,  the  unknown sample 
results were compared with a standard preparation of cachectin included in all bioassays. 
This standard preparation of crude cachectin was aliquoted into small tubes and stored at 
-80 ° C. 1 U ofbioactivity was defined as the amount ofcachectin yielding a PTS equivalent 
to that achieved by addition of 1.0 gl of the standard to the 1.0-ml assay system. Use of a 
standard solution of cachectin also assured a linear estimate of the amount of bioactivity 
present in unknown samples. 
Cachectin Production.  RAW 264.7  cells (10,  I 1) were grown to confluence in RPMI 
1640 medium (Gibco Laboratories) supplemented with  10% FBS, using 150-cm  2 T  flasks 
maintained at 37 °C in a  5% COs environment. Before induction of cachectin secretion, 
RAW  264.7  cells  were  washed  extensively  with  Hanks'  balanced  salt  solution  (Gibco 
Laboratories) buffered with 25 mM Hepes, pH 7.4 (Research Organics, Inc., Cleveland, 
OH) to remove contaminating serum proteins.  Each flask was stimulated with  100 ml of 
RPMI 1640 medium containing 1 ~g/ml of E coli LPS (Difco Laboratories, Inc., Detroit, 
MI) and  50  mM  Hepes,  pH  7.4.  After  22 h  of incubation  at  37°C,  the  medium  was 
filtered through a 0.22/~m filter and frozen at -20°C. 
Purification of  Cachectin.  855 ml of stored frozen medium was thawed and concentrated 
under 50 psi of nitrogen at 4°C using a  stirred cell with a  PM-10 filter (Amicon Corp., 
Danvers,  MA).  After  concentration  to  2%  of the  initial  volume,  the  retained  protein 
solution  was  repeatedly  diluted  with  distilled  water  and  reconcentrated  to  desalt  the 
sample before isoelectric focusing. 
Isoelectric focusing was performed at  4°C  in a  water-cooled column with  a  400  ml 
capacity. A glycerol gradient was prepared in this column with the protein sample layered 
in the center as follows: a linear gradient of glycerol from 40 to 21% (vol/vol) was added; 
the sample was supplied with a peristaltic pump; and a glycerol gradient of 19 to 0% (vol/ 
vol)  was  layered  above  the  sample.  Both  upper  and  lower  segments  of the  gradient 
contained  Servalyte,  pH  3-10  (Serva  Fine  Biochemicals,  Inc.,  Garden  City Park,  NY), 
diluted 1:16 with water. The sample was prepared by mixing the salt-free concentrate (55 
ml vol) with 4.3 ml Servalyte, pH 3-10, and  16.7 g glycerol. The anode solution (at the 
bottom of the column) was 0.01  M  imidodiacetic acid in 40% glycerol, and the cathode 
solution (at the top of the column) was 0.01  M ethylenediamine in H20. The separation 
was carried out at an initial current of 18 mA and an initial voltage of 630 V. The voltage 
was increased as current declined over the course of the run, but power output was not 
allowed to exceed 16 W. 986  CACHECTIN,  A  LIPOPROTEIN  LIPASE-SUPPRESSING HORMONE 
After 24 h, the column was drained under gravity into 150-drop fractions. Precipitated 
proteins were removed by centrifugation at 3,000 g for 20 min at 4 °C. A drop of phenol 
red solution was added to each decanted supernatant, and acidic samples were neutralized 
by addition  of saturated  tribasic  sodium  phosphate  solution,  while  basic  samples  were 
neutralized  by  addition  of  30%  phosphoric  acid  solution.  Cachectin  bioactivity  was 
determined by assaying 2 #1 from each fraction. Six fractions, corresponding to the peak 
of bioactivity, were pooled for further purification. 
The pooled peak fractions were dialyzed at 4°C against several changes of Dulbecco's 
phosphate-buffered saline (PBS) (Gibco Laboratories) to remove ampholytes and glycerol. 
The dialyzed  material  (94  ml  in  volume)  was passed  over a  concanavalin  A  (Con  A)- 
Sepharose column (Pharmacia Fine Chemicals,  Uppsala,  Sweden) with a bed volume of 
2.0 ml for  1 h at 4°C. An additional  10 ml of PBS was then run through the resin and 
pooled  with  the  rest  of the  filtrate.  The  filtrate  was  dialyzed  against  two  changes  of 
distilled water at 4°C and lyophilized. 
The sample was redissolved in 2 ml of a  solution containing 30 mM Tris-HCl buffer, 
pH 6.8, 5% glycerol, 1 mM/3-mercaptoethanol, and 0.002% bromphenol blue, and then 
subjected  to electrophoresis  under  nondenaturing  conditions.  The  sample  was applied 
across the stacking gel of a  1.5 mm x  14.2 cm ×  13.6 cm slab gel with a  6-13% linear 
polyacrylamide gradient.  A  Tris-glycine buffer system was used as follows: the cathode 
buffer was 38 mM Tris base and 40 mM glycine; the anode buffer was 63 mM Tris base 
and 50 mM HC1; the stacking gel buffer was 0.125 M Tris-HCl, pH 6.8; and the separating 
gel buffer was 0.375 M Tris-HCl, pH 8.8 (final concentrations). In addition to acrylamide 
(29.2%),  the  monomer solution  contained  0.8%  bis-acrylamide.  To remove impurities, 
the  monomer solution was stirred  overnight with  Amberlite  MB-1  resin  (Mallinckrodt, 
Inc., St.  Louis, MO). The sample was electrophoresed at 4°C with a constant current of 
20 mA until the bromphenol blue marker reached the bottom of the gel. After completion 
of electrophoresis,  1 cm of gel was removed from the lateral  margins of the slab,  since 
voltage artifacts caused nonhorizontai migration in these regions, and the remainder of 
the gel was sliced horizontally at 2-mm intervals.  The protein was recovered from each 
slide by allowing it to diffuse into 2 ml of a 50 mM ammonium bicarbonate solution in a 
polypropylene tube over a period of 12 h at 4 °C with gentle agitation. Electroelution was 
carried out in a  tube gel apparatus against a  3,500-dalton-cutoff dialysis membrane,  as 
described by Francis et al. (12). The fractions thus obtained were assayed for activity, and 
subjected to polyacrylamide gel electrophoresis in a denaturing system containing sodium 
dodecyl  sulfate  (SDS-PAGE)  in  10-15%  linear  gradient  gels  under  nonreducing  and 
reducing conditions to assess purity. The protein bands were visualized by silver staining 
as previously described (13). 
Analytical  Column  Chromatography.  Gel  filtration  was  carried  out  using  fine  grade 
Sephadex G-75 (Pharmacia Fine Chemicals) in a 7 mm x  1 m  glass column, equilibrated 
with  0.1  M  ammonium  bicarbonate,  pH  7.8.  Enzyme grade  urea  (Bethesda  Research 
Laboratories, Bethesda, MD) was added to the sample and the eluant buffer in experiments 
aimed  at  determining  cachectin  subunit  size,  and  fractions  were  individually  dialyzed 
against PBS before bioassay. 
Studies  With  Radioiodinated  Cachectin.  Purified  cachectin  was  radiolabeled  by  the 
iodogen  method  (14).  The  free  iodide  was removed  by Sephadex  G-25  gel  filtration 
followed  by extensive  dialysis.  Binding  studies  were  carried  out  using  24-well  Linbro 
plates containing recently differentiated  3T3-L1  cells (4 ×  105 cells per 0.2 ml system). 
The solution used for binding studies consisted of DME medium, containing  10%  FBS, 
50 ng/ml insulin, and 50 mM Hepes buffer, pH 7.4. Varying quantities of labeled cachectin 
were added to this solution. Except where otherwise noted, the incubations were carried 
out on ice for 4 h, with slow agitation. The cell monolayers were then washed three times 
with  1.0 ml of medium, solubilized with  1.0 ml of 1 M NaOH, and counted in a gamma 
counter for a length of time sufficient to yield a standard error of <5%. 
The muscle cell line C2 (the kind gift of Dr. Helen Blau of Stanford University Medical 
School,  Palo  Alto,  CA)  was also  analyzed  for cachectin  binding.  Cells  were  grown  to 
confluence in 24-well Linbro plates.  The plates were pretreated  with calf skin collagen BEUTLER  ET  AL.  987 
(Calbiochem-Behring Corp.,  La Jolla,  CA) by autoclaving 50  mg of collagen in  35  ml 
water and applying the sterile solution to each of the 24 wells per plate. The solution was 
then aspirated and the plates allowed to dry under ultraviolet light in a laminar flow hood. 
Growth medium used was DME supplemented with  20%  FBS and 0.5%  chick embryo 
extract (Gibco Laborories). Cultures were maintained at 37 °C in a 5% CO2 environment. 
The medium was changed daily, and cells were induced to form myotubules when they 
reached confluence by addition of DME containing 2% horse serum (Gibco Laboratories). 
After 48 h, the cells were used for binding studies. Measurement of cachectin binding to 
C2 myotubules was performed in a manner identical to that described for 3T3-L1 cells. 
NCS female mice were obtained from the Laboratory Animal Research Center of The 
Rockefeller University. Mouse erythrocytes (RBC) were obtained by filtration of heparin- 
ized mouse blood over a  microcrystalline cellulose column as previously described (15). 
Splenic lymphocytes were obtained by FicolI-Hypaque (Pharmacia Fine Chemicals) sedi- 
mentation.  Measurements of cachectin  binding  to erythrocytes and  lymphocytes were 
undertaken  with  the  use of the same procedures applied in  the case of 3T3-L1  cells. 
However, incubation with  labeled cachectin was performed in  1.5-ml Eppendorf tubes 
(Brinkmann Instruments, Inc., Westbury, NY). 4 x  107 mouse RBC and  1 X 107 mouse 
lymphocytes were used in each binding assay. Washing was accomplished by centrifuging 
three times at 4°C using a microfuge (Beckman Instruments, Inc., Fullerton, CA). The 
pellets of cells were counted directly. 
Crude  hepatocyte membranes were prepared by homogenization of 2 g  mouse liver 
(wet weight) in  10 ml of 5 mM Hepes, pH 7.4.  The homogenate was diluted to 50 ml 
with the same buffer and centrifuged at 200 g at 4°C for 5 min. The supernatant was 
divided into 2-ml aliquots and pelleted at 48,000 g in a  10 min spin. The resulting pellets 
were each suspended in 0.5 ml of DME supplemented with  10%  FBS,  to which labeled 
cachectin (1 ng/ml) was added, with or without unlabeled cachectin (300 ng/ml). Binding 
was allowed to occur for 4 h at 4 °C. The membranes were then washed three times with 
fresh medium by centrifugation at 48,000 g. The pellets were counted for radioactivity. 
Assays oflnterleukin  I (IL-I) Activity.  These were carried out as previously described 
(16), using recombinant I L-1 (17) as a standard preparation. 
Protein Determination.  Estimates of protein concentration  were made by means of a 
commercial Coomassie-based protein reagent (Bio-Rad Laboratories, Richmond, CA). 
Results 
Preparation  of Cachectin from  RAW 264.7  Cells  and  Characteristics  in  Crude 
Solution.  ~ 105 U  of cachectin bioactivity in 50 ml of medium could be obtained 
from a  confluent flask containing  108  RAW 264.7  cells. The specific activity of 
the crude material was routinely observed to be ~4  x  105  U/mg protein.  Very 
little  additional  cachectin  could  be obtained  by longer  incubation  of the  cells 
with  LPS,  or  by  restimulation  with  fresh  medium  containing  LPS.  On  the 
contrary, a drop in specific activity was observed when such attempts were made. 
No  loss  in  bioactivity  was  observed over  several  weeks  after  storage  of the 
crude  preparation  at  neutral  pH  at  -20°C,  or  over  5 d  at  4°C.  However, 
bioactivity was noted to be labile at acid pH, with  a  half-life of 24 h  at  4°C  at 
pH 5.0. Lability at low pH could be diminished by addition of 20% glycerol. For 
this reason,  isoelectric focusing was carried out in glycerol rather than sucrose, 
and this step was performed as rapidly as possible. 
Concentration  and  Isoelectric  Focusing.  Bioactivity  was  associated  exclusively 
with  the  retentate  when  pressure dialysis was performed under  the  conditions 
described.  Recovery after a  50-fold concentration  was generally >90%, and was 
occasionally enhanced  (Table I). The data in Table I  are from a  representative 
isolation; to date, the procedure outlined there has been followed 11  times. 988  CACHECTIN,  A  LIPOPROTEIN  LIPASE-SUPPRESSING HORMONE 
TABLE  I 
Step  Volume  Total activ-  Total pro-  Specific ac-  Fold purifi-  Recovery 
ity*  tein*  tivity  cation 
ml  U  mg  U/mg 
Unconcentrated crude  855  2.5 x  107  53.9  4.6 ×  105  --  100 
Concentrated crude  54  2.7 x  107  38.9  6.9 ×  105  1.5  108 
Isoelectric focusing  94  1.5 x  107  3.88  3.9 x  106  8.5  60 
Con A-Sepharose  104  1.4 x  107  2.78  5.0 x  106  11  56 
Nondenaturing PAGE  8  1.1  x  106  0.03  1.8 x  107  80  2 
* Determined as described in text. 
* Determined by protein assay  (Bio-Rad Laboratories) except in the final step, when estimate was 
made by silver stain, with reference to a myoglobin standard. 
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FIGURE  1.  Preparative isoelectric focusing of cachectin.  150-drop fractions were obtained 
by draining the isoelectric focusing column under gravity as described in the text, and cachectin 
bioassays were  performed on  2.0-gl  aliquots  taken  from  each  fraction.  Each  open  circle 
represents the result of a separate bioassay. Fractions in the region of the peak were assayed 
in duplicate or in triplicate. The units of bioactivity are described in Materials and Methods. 
The dashed curve indicates the pH gradient that was established. 
Isoelectric focusing of the  concentrated  material  revealed only one peak  of 
bioactivity with an isoelectric point of 4.7 (Fig.  1). Ampholytes by themselves do 
not interfere with the bioassay. Recovery of bioactivity after isoelectric focusing 
was variable (10-60%) and depended to a  large extent upon the total quantity 
of protein added to the column. The loss of bioactivity during isoelectric focusing 
appeared to result from coprecipitation of cachectin with other proteins present 
in the crude concentrate,  since poor yields were associated with separations of 
large quantities  of protein  and the  formation  of large  amounts of precipitate. 
Later  experiments  in  which  radiolabeled  purified  cachectin  was added  to  the 
crude material as a tracer before isoelectric focusing supported this conclusion. 
Recovery was maximized by addition  of a  small sample to the column (50 mg 
total protein or less),  the use of a glycerol gradient, and a short separation time 
(24 h or less), with immediate neutralization of samples after fractionation. 
Con A-Sepharose Chromatography.  Several protein  species were removed by 
affinity chromatography on Con A-Sepharose with little or no loss of bioactivity. BEUTLER  ET  AL.  989 
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FIGURE 2.  Preparative PAGE of cachectin. After isoelectric focusing and Con A-Sepharose 
chromatography, the sample was subjected to electrophoresis under nondenaturing conditions 
as described in the text. Serial 2-ram slices were cut from the gel and the bioactivity was eluted 
from each slice by allowing diffusion into ammonium bicarbonate solution.  Bioassays  were 
performed on 1-tal aliquots of each fraction. Units of bioactivity are plotted against the position 
at which each slice was made (relative to the bottom of the gel). Only one peak of activity is 
resolved, wbich corresponds to a single protein band visible upon staining of the nondenaturing 
gel. 
Use  of larger  quantities  of Con  A-Sepharose  resulted  in  lower  recovery of 
cachectin activity, possibly because of hydrophobic interaction with the resin, 
since the activity could not be released by addition of 0.1 M ot-methylmannoside. 
PAGE.  After PAGE under nondenaturing conditions, all of the bioactivity 
was found in one location on the gel, associated with a single protein band (Fig. 
2,  3).  In this step, only 10-20% of the bioactivity could be recovered from the 
sliced gel, either by electroelution or by allowing diffusion of the protein into 
dilute ammonium bicarbonate buffers. Longer diffusion times, repeated extrac- 
tion, and the use of larger volumes of buffer had little effect. In our experience, 
recovery was maximized by the application of a  highly concentrated sample to 
the gel, and by the use of purified acrylamide monomer in gel preparation. 
SDS-PAGE  Analysis  of Electrophoretically Purified  Cachectin.  The  apparent 
homogeneity of the isolated product was confirmed by electrophoresis in an SDS- 
PAGE system. The purified protein associated with cachectin activity, applied to 
SDS  gels,  yielded a  single band  of molecular weight  17,000  (Fig.  3).  When 
microgram quantities of purified cachectin were electrophoresed in  SDS gels, 
bioactivity could be recovered from unfixed slices by electroelution. The activity 
coincided with the presence of the  17,000  mol wt protein;  no bioactivity was 
obtained from other regions of the gel (Fig. 4). 
Molecular Weight of  Purified Cachectin.  When crude concentrates of cachectin 
were analyzed by means of Sephadex G-75 gel filtration, the bioactivity elution 
profile indicated a  molecular weight in >70,000.  A  molecular weight estimate 
of 17,000 (dextran scale) was obtained, however, when crude concentrates were 
separated by gel filtration in the presence of 6 M urea, suggesting the formation 
of noncovalent muhimers or aggregates with other proteins (data not shown). 990  CACHECTIN,  A  LIPOPROTEIN  LIPASE-SUPPRESSING  HORMONE 
FIGURE 3.  SDS-PAGE analysis of fractions from cachectin isolation. Samples of crude me- 
dium  from endotoxin-induced  and  noninduced  RAW  264.7  cell cultures,  and purification 
intermediates were subjected to SDS-PAGE in a  10-15%  linear polyacrylamide gradient gel. 
Samples were dialyzed against distilled water before electrophoresis. (1)  150 #1 of noninduced 
RAW 264.7  cell medium; (2) 50 #1 of induced RAW 264.7 cell medium; (3)  10 ul sample of 
pooled  fractions  from  isoelectric focusing column;  (4)  25  ~1  sample  of Con  A-Sepharose 
filtrate;  (5)  80-ul  sample  of the  peak  fraction  obtained  by  PAGE  under  nondenaturing 
conditions (homogeneous cachectin). Arrows indicate cachectin, which is entirely absent from 
the medium of noninduced cells,  but is a major constituent of the medium of induced cells. 
Cachectin is successively enriched by the purification steps listed above. The high molecular 
weight bands visible in all lanes (including spacer lanes)  are 13-mercaptoethanol contaminants, 
and are not present in the samples themselves. 
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FIGURE 4.  SDS-PAGE analysis of purified cachectin. A  20-ug sample of purified cachectin 
was boiled for 2 min in the presence of SDS and subjected to electrophoresis under denaturing 
conditions in a  10-15% linear polyacrylamide gradient gel. Serial 2-mm slices of this gel were 
electroeluted as described in the text. The electroelution fractions were diluted  I:100 with 
DME  containing  10%  FBS,  and  10-#1 aliquots  were  assayed  for  bioactivity.  The  peak  of 
bioactivity  corresponded  precisely  to  the  locations  of  the  cachectin  monomer.  This  was 
confirmed by reelectrophoresis of the eluates in a second SDS gel, followed by silver staining 
(data not shown).  No bioactivity was found elsewhere in the gel. Arrows indicate the position 
of molecular weight standards. BEUTLER  ET  AL.  991 
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FIGURE 5.  Binding of cachectin to 3T3-L 1 cells. Individual monolayers of 3T3-LI cells were 
exposed for varying lengths of time to radiolabeled, purified cachectin (40 U/ml bioactivity). 
Cachectin associated rapidly and specifically with intact 3T3-L1  cells at 37°C (a) and at 0°C 
(b) (solid lines). Nonspecific binding was determined at both temperatures by addition of an 
excess of unlabeled crude cachectin (25,000 U/ml; dotted lines). Data are expressed in terms 
of the  percentage of input radioactivity binding to  cell  monolayers as a  function of time. 
Duplicate or triplicate assays were performed at each time point. Details of the binding assay 
are provided in the text. 
When purified cachectin was analyzed on SDS gels, both reduced and nonre- 
duced samples exhibited an apparent molecular weight of 17,000. Gel filtration 
of purified cachectin on Sephadex G-75 columns provided an estimated molec- 
ular weight of 35,000, indicating the presence of noncovalent dimers (data not 
shown). 
Badioiodination and Binding Studies.  The purified hormone was radiolabeled 
with  ]25I by the iodogen method.  -70% of the bioactivity was recovered, with 
an initial specific activity of ~ 1 ×  106 cpm/#g protein. The labeled material was 
subjected to  SDS-PAGE,  and  measurement  of sliced gels showed most of the 
radioactivity to be associated with the  17,000 mol wt protein.  Attempts to label 
the protein using chloramine T  resulted in a complete loss of bioactivity. 
The purified,  radioiodinated  hormone  was rapidly and specifically bound by 
cultured  3T3-L1  adipocytes at both  37 and  0°C (Fig.  5,a and  b). Addition  of 
25,000 U/ml of unlabeled cachectin prevented binding by the labeled protein at 
all  time  points  examined.  Equilibrium  was  achieved  within  2-3 h  under  the 
conditions described.  A  time-dependent  decline in the quantity of label bound 
was observed at 37 ° C, possibly reflecting receptor-mediated endocytosis. 
The  characteristics  of binding  were exained  by Scatchard analysis (Fig.  6a). 
The  data  suggest  the  existence  of  -104  high-affinity  sites  per  cell,  and  an 
association  constant  (Ka) of  3  ×  109. Both  differentiated  3T3-L1  cells  and 
undifferentiated  "pre-adipocytes" possessed receptors,  with similar affinity and 992  CACHECTIN,  A  LIPOPROTEIN  LIPASE-SUPPRESSING HORMONE 
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FIGURE 6.  Scatchard analysis of t25I-cachectin  binding to intact differentiated 3T3-L1  cells 
and C2  myotubules. Individual monolayers of 3T3-L1  cells (a) or C2  myotubules (b) were 
exposed to  increasing concentrations of radiolabeled cachectin, 0.5-30  ng/ml. Each  point 
represents a measurement of cachectin binding to a cell monolayer at a concentration in the 
range noted above. B, counts bound; F, counts not bound (calculated by subtracting B from 
input. Calculation of molar concentration assumes a molecular weight of 17,000, and a reaction 
volume of 0.2 ml. 4 X 105 3T3-L1  cells or C2 cells were present per monolayer. 
density.  The  muscle cell  line  C2  also  possessed a  specific cachectin  receptor. 
Again,  ~10 4 high-affinity sites per cell and a K~ of 3 ×  10 9  were  observed (Fig. 
6 b). Mouse liver membrane preparations also exhibited specific cachectin binding 
(data  not  shown).  On  the  other  hand,  erythrocytes  and  lymphocytes  lacked 
detectable quantities of cachectin receptor (<200 copies per cell). 
Assays for  IL-1  Activity.  In  view  of  its  similar  size,  tissue  of  origin,  and 
endotoxin inducibility, it appeared possible that the protein isolated was identical 
to IL-1. The large quantity of cachectin produced by RAW 264.7 cells suggested 
that this was not the case, particularly since it was found that the cells produced 
very little IL-1, as measured by leukocyte-activating factor (LAF) activity under 
the  conditions  used  to  elicit  cachectin.  Purified cachectin  preparations  lacked 
LAF activity when  assayed over a  wide range  of concentrations  up to  1 nM, 
under  conditions  at  which  recombinant  IL-1  could  be  detected  at  10 -]1  M. 
Moreover, micromolar concentrations of highly purified recombinant IL-1 failed 
to compete with the radioiodinated cachectin for receptor binding.  It therefore 
appears that cachectin is distinct from IL-1. 
Discussion 
In the present paper, we describe the isolation of a unique macrophage protein 
that  is responsible for suppression  of LPL activity in  3T3-L1  adipocytes. The 
purified protein has a monomeric molecular weight of 17,000 on SDS gels, and 
an isoelectric point of 4.7.  Under nondenaturing  conditions, purified cachectin 
apparently exists as a dimer. 
1 U of bioactivity corresponds to ~2 ×  10  -15 mol of isolated monomer. Thus, 
a  2  pM  solution  of cachectin  is  readily  detectable  by means  of the  bioassay 
described.  This  estimate of specific activity must be considered minimal,  since 
an unknown quantity of the protein may have been rendered biologically inactive 
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The isolation of cachectin was facilitated by the use of the murine macrophage 
cell  line  RAW  264.7,  which allowed large-scale  production  of the protein  for 
analysis and  purification.  In addition  to being a  homogeneous population,  the 
cells could be maintained  in serum-free medium during endotoxin stimulation. 
The  RAW  264.7  cell  line  was  generated  through  transformation  of mouse 
peritoneal cells by Abelson leukemia virus (I0,  1 I). The cells resemble macro- 
phages morphologically and functionally. They possess receptors for complement 
and  Fc fragments  of IgG,  and  are able to phagocytose neutral  red,  opsonized 
RBC, and latex beads. We have previously demonstrated (4) marked similarity 
between the cachectin activity produced by RAW 264.7 cells and that produced 
by thioglycollate-elicited  peritoneal  macrophages.  Further  work  is  needed  to 
prove actual identity. 
SDS-PAGE  analysis  of culture  medium  derived  from  LPS-stimulated  and 
unstimulated  RAW  264.7  cells  revealed  that  cachectin  is  one  of the  major 
endotoxin-inducible secretory proteins.  It constitutes  1-5% of the total protein 
secreted by stimulated RAW 264.7 cells, and is clearly visible as a distinct 17,000 
tool wt  band  on  SDS  gels.  Medium  from  unstimulated  cells completely  lacks 
cachectin bioactivity and  the  17,000  mol wt band.  It would appear,  based on 
estimates of the specific activity of purified  cachectin,  that  the  17,000  tool wt 
protein accounts for most, if not all, of the bioactivity present in conditioned cell 
medium. 
The possible relationship  of cachectin to other monokines (e.g., interferons, 
glucocorticoid-antagonizing factor, tumor necrosis factor (TNF), or other bioac- 
tivities produced by macrophages) has not been fully assessed. Purified IL-2 and 
crude TNF  preparations  appear  to  lack  LPL-suppressing activity (our unpub- 
lished observation).  From  the bioactivity data presented  above, it is clear that 
cachectin is distinct from IL-1, despite similar molecular weights and isoelectric 
points. 
Using labeled cachectin, we have demonstrated the existence of specific recep- 
tors for cachectin on differentiated  3T3-L 1 cells and preadipocytes, C2 muscle 
cells, and  mouse liver cell membranes.  On  the other hand,  receptors were not 
detected on mouse-erythrocytes or lymphocytes. The receptor density on 3T3- 
L1 cells and on C2 cells was ~104 per cell. The Ka in both cases was determined 
to be 3 x  109. From the value of the Ka, the degree of receptor occupancy can 
be determined  as a  function  of cachectin  concentration.  It  would appear  that 
occupancy of as few as 5% of the receptors present on a  3T3-L1  cell (achieved 
at 2 x  10  -~t  M) is sufficient to elicit 70-80%  suppression of LPL. This type of 
relationship has been noted with many other hormone receptor-binding systems. 
Although the macrophage is not a characteristic endocrine cell, it can produce 
a  monokine,  cachectin,  which  may be described as a  hormone  in  the  classical 
sense, since it is produced by a  specific group of ceils, and influence, via a  high 
affinity receptor, the behavior of other cell types. As such, it provides an example 
of the endocrine capabilities of reticuloendothelial cells. In view of the fact that 
muscle, liver, and adipose tissues possess receptors for cachectin, a wide range of 
biological responses is anticipated. 
We hypothesize that cachectin may serve to mobilize the energy reserves of a 
mammal  confronted by acute infection,  to meet increased metabolic demands. 994  CACHECT1N,  A  LIPOPROTEIN  LIPASE-SUPPRESS1NG HORMONE 
When chronically evoked, as in parasitic infections, cachectin may contribute to 
the  protein and  lipid  catabolism  that  ultimately  reduce the  host  to a  state  of 
cachexia. Further inquiry into this potential role of cachectin will be facilitated 
by the availability of pure material, and by the use of the receptor as the basis of 
a highly specific assay. 
Summary 
Previous studies have indicated that endotoxin and other bacterial and proto- 
zoal products can stimulate macrophages to produce a  factor that can suppress 
the activity of the enzyme lipoprotein lipase (LPL), in vivo and in vitro. In the 
present report we describe the purification of this factor, cachectin, to apparent 
homogeneity from the conditioned medium ofendotoxin-stimulated RAW 264.7 
cells. The isolated protein has an isoelectric point of 4.7 and a subunit molecular 
weight of 17,000.  Although  cachectin's isoelectric point and  molecular weight 
are similar to those described for interleukin  1, pure cachectin has no leukocyte- 
activating factor (LAF) activity. 
Cachectin at a  concentration of 10 -1~  M  has the ability to suppress the  LPL 
activity of the  3T3-L1  adipocyte cell line by 80%.  Binding studies using radio- 
labeled  cachectin  and  3T3-L1  adipocytes  and  C2  myotubules  revealed  ~104 
high-affinity  receptors  per  cell  on  both  cell  types  (Ka,  3  X  109).  Cachectin 
receptors were also present on liver membranes but were absent on erythrocytes 
and lymphocytes. 
The isolation of cachectin and characterization of its receptor should facilitate 
further investigations into the role of cachectin and other macrophage mediators 
in the metabolic derangements that occur during infection and cachexia. 
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Note added in proof" We have recently obtained N-terminal sequence data for cachectin, and noted 
strong homology to the sequence for human TNF. We are currently investigating the relationship 
between these two molecules. 
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